Clinical Studies & Trials
Selected ARDL Trial Studies for FY16 - FY23
EDIC
NHANES
NHANES Central Biochemistry Laboratory (9/2021): National Health and Nutrition Examination Survey
Anthony Killeen, MD., PhD., Principal Investigator
NHANES Lipids (4/14/19): National Health and Nutrition Examination Survey
John Eckfeldt, MD., PhD., Principal Investigator
MESA
MESA Kidney (8/31/16): Multi-Ethnic Study of Atherosclerosis
John Eckfeldt, MD., PhD., Principal Investigator
Sprint
Sprint (9/30/18)-Systolic Blood Pressure Intervention Trial: Blood pressure intervention trial
Anthony Killeen, MD., PhD., Principal Investigator
ARIC
ARIC (12/31/2020)-- Diabetes and Prediabetes in Older Adults in ARIC (Atherosclerosis Risk in Communities)
HCHS / SOL
HCHS Visit 2 (Hispanic Community Health Study) (5/31/2019): Hispanic acculturation and disease development / SOL Youth (11/30/15): Study of Latino children's overall health
HRS
HRS (12/31/17): Health in retirement age population
Bharat Thyagarajan, MD., PhD., MPH, Principal Investigator
GRADE
GRADE (7/31/17): Glycemic reduction in diabetes effectiveness / GRADE - EDS substudy (3/31/20): Ancillary to GRADE
Michael Steffes, MD., PhD., Principal Investigator
PERL
PERL (6/30/18): Project with Joslin Diabetes
Amy Karger, MD., PhD., Principal Investigator
ASSESS
ASSESS (6/30/19): Long term outcomes in acute kidney injury / ASSESS-AKI ancillary (Liu) (6/30/18): Ancillary to ASSESS
Michael Steffes, MD., PhD., Principal Investigator
CKiD Study
CKiD Study (2018-2023): An NIH-funded, multicenter, prospective cohort study of children aged 6 months to 16 years with mild to moderate impaired kidney function
Jesse Seegmiller, PhD., Principal Investigator